Evidence map›Paper›PMID 39363326›Full record

ArticleInfectious agents and cancer2024

Factors affecting Kaposi's sarcoma-associated herpesvirus transmission in rural Ugandan households, a longitudinal study.

Katherine R Sabourin, Vickie A Marshall, Will Eaton, Beatrice Kimono, Joseph Mugisha, Wendell J Miley, Nazzarena Labo, Gabriela Samayoa-Reyes, Denise Whitby, Rosemary Rochford and 1 more

Abstract read
In one paragraph

Article in Infectious agents and cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Katherine R SabourinDepartment of Environmental and Public Health Sciences, University of Cincinnati, Cincinnati, OH, USA. sabourke@ucmail.uc.edu.
Vickie A MarshallViral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Frederick, Frederick, MD, USA.
Will EatonDepartment of Tropical Medicine and Infectious Disease, Tulane University, New Orleans, LA, USA.
Beatrice KimonoMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
Joseph MugishaMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
Wendell J MileyViral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Frederick, Frederick, MD, USA.
Nazzarena LaboViral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Frederick, Frederick, MD, USA.
Gabriela Samayoa-ReyesDepartment of Immunology and Microbiology, University of Colorado, Aurora, CO, USA.
Denise WhitbyViral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Frederick, Frederick, MD, USA.
Rosemary RochfordDepartment of Immunology and Microbiology, University of Colorado, Aurora, CO, USA.
Robert NewtonMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6M
The synergistic contributions of EBV and malaria to the etiology of Burkitt lymphomaR01AI141531 · NIAID · UNIVERSITY OF COLORADO DENVER · PI SAMAYOA REYES, GABRIELA M · 2020 to 2024
$3.6M
Environmental determinants of KSHV transmission in rural UgandaR01CA239588 · NCI · UNIVERSITY OF COLORADO DENVER · PI ROBERT, NEWTON, SABOURIN, KATHERINE R · 2019 to 2023
$2.6M
National Cancer Institute, National Institutes of Health contract number HHSN261201500003I and NCI contract 75N91019D00024National Cancer Institute, National Institutes of Health R01 CA239588, AI141531NCI NIH HHS 75N91019D00024NCI NIH HHS HHSN261201500003CNCI NIH HHS HHSN261201500003INCI NIH HHS R01 CA239588NIAID NIH HHS R01 AI141531UK Medical Research Council (MRC) and the UK Department for International Development (DFID) The Ugandan General Population Cohort study is funded under the MRC/DFID Concordant Agreement
6 · The paper itself

Abstract

backgroundWe report the impact of HIV infection within a household on oral Kaposi's sarcoma-associated herpesvirus (KSHV) shedding.

methodsWe enrolled 469 individuals from 90 households. Mouthwash rinse samples collected at three monthly visits were analyzed for KSHV DNA using quantitative polymerase chain reaction (qPCR). Generalized linear mixed effects logistic models were applied to analyze factors associated with KSHV ever shedding, and among shedders, always versus intermittent shedding. Linear mixed effects models were applied to models of KSHV viral loads. Intraclass correlation coefficients (ICCs) were calculated to assess the contribution of household-level factors to variations in shedding probabilities. Hotspot analyses of geospatial feature clusters were calculated using Getis-Ord Gi* statistic and visualized using inverse distance weighted interpolation.

resultsAnalyses included 340 KSHV seropositive individuals, aged 3 + years, with qPCR results from 89 households. Forty households had 1 + persons living with HIV (PLWH), while 49 had none. Among participants, 149(44%) were KSHV ever shedders. Of 140 who shed KSHV at two or more visits, 34(24%) were always shedders. Increasing number of KSHV seropositive household members was significantly associated with ever shedding [Odds ratio(OR) (95% Confidence Interval(95%CI)):1.14(1.03,1.26);p = 0.013]. Among KSHV shedders, a statistically significant age-related trend was identified with 10-19 years being more likely to be always shedders (type III test p = 0.039) and to have higher viral loads (type III test p = 0.027). In addition, higher viral loads were significantly associated with increasing number of household members [coefficient(95%CI):0.06(0.01,0.12);p = 0.042], increasing number of KSHV seropositive members [coefficient(95%CI):0.08(0.01,0.15);p = 0.021], and living in households with 1 + PLWH [coefficient(95%CI):0.51(0.04,0.98);p = 0.033]. Always shedders exhibited higher viral loads than intermittent shedders [coefficient(95%CI):1.62(1.19,2.05);p < 0.001], and viral loads increased with the number of visits where KSHV DNA was detected in saliva (type III test p < 0.001). Household-level factors attributed for 19% of the variability in KSHV shedding (ICC:0.191;p = 0.010). Geospatial analysis indicated overlapping hotspots of households with more KSHV seropositive individuals and KSHV shedders, distinct from areas where PLWH were clustered. DISCUSSION: KSHV oral shedding is influenced by multiple factors at the individual, household, and regional levels. To mitigate ongoing KSHV transmission a comprehensive understanding of factors contributing to oral KSHV reactivation and transmission within households is needed.

Indexed as

HHV-8HIVHousehold cohortKaposi’s sarcoma-associated herpesvirusKSHVLongitudinal follow-upSalivaSheddingSub-saharan AfricaTransmission

Identifiers

PMID39363326
PMCPMC11451123

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.